Checking TARS unusual options activity helps you spot when traders are making outsized bets on Tarsus Pharmaceuticals Inc before the broader market catches on. Tarsus Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TARS unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TARS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TARS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TARS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases.
Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Catalysts rarely arrive without a footprint, and TARS unusual options activity is often where that footprint shows up first. Our scanner tracks Tarsus Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TARS unusual options volume on the call side or chasing put sweeps, Tarsus Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
